{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "5fe5c70b-6f49-4caa-bb6d-e8481c5efa30",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "63b4183d-6f08-4c99-9228-c0a14880c911",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_excel('Final_Capstone_Spreadsheet.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "8ff62e40-f2a4-420d-b7c8-8129129f6ffe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>Company Name</th>\n",
       "      <th>Ticker Symbol</th>\n",
       "      <th>Country of Origin</th>\n",
       "      <th>Company Age</th>\n",
       "      <th>Est. Market Capitalization</th>\n",
       "      <th>Total Liabilities</th>\n",
       "      <th>D/E Ratio</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2021</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2020</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2019</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2018</th>\n",
       "      <th>Number of Research Areas Covered by R&amp;D Pipeline</th>\n",
       "      <th>No. of Ongoing Phase 1 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 2 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 3 Clinical Trials</th>\n",
       "      <th>Filed</th>\n",
       "      <th>Total in Pipeline</th>\n",
       "      <th>Total Approved Treatments on the Market in the U.S.A.</th>\n",
       "      <th>No. of Employees</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Johnson &amp; Johnson</td>\n",
       "      <td>JNJ</td>\n",
       "      <td>USA</td>\n",
       "      <td>136</td>\n",
       "      <td>449870000000</td>\n",
       "      <td>101367000000</td>\n",
       "      <td>0.225325</td>\n",
       "      <td>3422.0</td>\n",
       "      <td>2840.00</td>\n",
       "      <td>2599.00</td>\n",
       "      <td>2508.00</td>\n",
       "      <td>6</td>\n",
       "      <td>25</td>\n",
       "      <td>24</td>\n",
       "      <td>39</td>\n",
       "      <td>11</td>\n",
       "      <td>99</td>\n",
       "      <td>67</td>\n",
       "      <td>141700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>Eli Lilly</td>\n",
       "      <td>LLY</td>\n",
       "      <td>USA</td>\n",
       "      <td>146</td>\n",
       "      <td>292110000000</td>\n",
       "      <td>38404400000</td>\n",
       "      <td>0.131472</td>\n",
       "      <td>1708.9</td>\n",
       "      <td>1465.40</td>\n",
       "      <td>1380.90</td>\n",
       "      <td>1280.90</td>\n",
       "      <td>5</td>\n",
       "      <td>26</td>\n",
       "      <td>18</td>\n",
       "      <td>36</td>\n",
       "      <td>4</td>\n",
       "      <td>84</td>\n",
       "      <td>46</td>\n",
       "      <td>35000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>PFE</td>\n",
       "      <td>USA</td>\n",
       "      <td>173</td>\n",
       "      <td>276440000000</td>\n",
       "      <td>101155000000</td>\n",
       "      <td>0.365920</td>\n",
       "      <td>3447.0</td>\n",
       "      <td>2300.00</td>\n",
       "      <td>2283.00</td>\n",
       "      <td>2008.00</td>\n",
       "      <td>6</td>\n",
       "      <td>34</td>\n",
       "      <td>34</td>\n",
       "      <td>28</td>\n",
       "      <td>8</td>\n",
       "      <td>104</td>\n",
       "      <td>314</td>\n",
       "      <td>79000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Roche</td>\n",
       "      <td>ROG.SW</td>\n",
       "      <td>Switerland</td>\n",
       "      <td>126</td>\n",
       "      <td>247350000000</td>\n",
       "      <td>57790000000</td>\n",
       "      <td>0.233637</td>\n",
       "      <td>3874.0</td>\n",
       "      <td>3406.00</td>\n",
       "      <td>3344.00</td>\n",
       "      <td>3165.00</td>\n",
       "      <td>7</td>\n",
       "      <td>65</td>\n",
       "      <td>29</td>\n",
       "      <td>52</td>\n",
       "      <td>32</td>\n",
       "      <td>178</td>\n",
       "      <td>47</td>\n",
       "      <td>100920</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>Novo Nordisk</td>\n",
       "      <td>NVO</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>98</td>\n",
       "      <td>262070000000</td>\n",
       "      <td>144476000000</td>\n",
       "      <td>0.551288</td>\n",
       "      <td>1771.0</td>\n",
       "      <td>1639.25</td>\n",
       "      <td>1601.75</td>\n",
       "      <td>2582.25</td>\n",
       "      <td>11</td>\n",
       "      <td>9</td>\n",
       "      <td>6</td>\n",
       "      <td>13</td>\n",
       "      <td>2</td>\n",
       "      <td>30</td>\n",
       "      <td>22</td>\n",
       "      <td>50816</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank      Company Name  Ticker Symbol Country of Origin  Company Age  \\\n",
       "0     1  Johnson & Johnson           JNJ               USA          136   \n",
       "1     2          Eli Lilly           LLY               USA          146   \n",
       "2     3             Pfizer           PFE               USA          173   \n",
       "3     4              Roche        ROG.SW        Switerland          126   \n",
       "4     5       Novo Nordisk           NVO           Denmark           98   \n",
       "\n",
       "   Est. Market Capitalization  Total Liabilities  D/E Ratio  \\\n",
       "0                449870000000       101367000000   0.225325   \n",
       "1                292110000000        38404400000   0.131472   \n",
       "2                276440000000       101155000000   0.365920   \n",
       "3                247350000000        57790000000   0.233637   \n",
       "4                262070000000       144476000000   0.551288   \n",
       "\n",
       "   R&D Expense 3rd Quarter 2021  R&D Expense 3rd Quarter 2020  \\\n",
       "0                        3422.0                       2840.00   \n",
       "1                        1708.9                       1465.40   \n",
       "2                        3447.0                       2300.00   \n",
       "3                        3874.0                       3406.00   \n",
       "4                        1771.0                       1639.25   \n",
       "\n",
       "   R&D Expense 3rd Quarter 2019  R&D Expense 3rd Quarter 2018  \\\n",
       "0                       2599.00                       2508.00   \n",
       "1                       1380.90                       1280.90   \n",
       "2                       2283.00                       2008.00   \n",
       "3                       3344.00                       3165.00   \n",
       "4                       1601.75                       2582.25   \n",
       "\n",
       "   Number of Research Areas Covered by R&D Pipeline  \\\n",
       "0                                                 6   \n",
       "1                                                 5   \n",
       "2                                                 6   \n",
       "3                                                 7   \n",
       "4                                                11   \n",
       "\n",
       "   No. of Ongoing Phase 1 Clinical Trials  \\\n",
       "0                                      25   \n",
       "1                                      26   \n",
       "2                                      34   \n",
       "3                                      65   \n",
       "4                                       9   \n",
       "\n",
       "   No. of Ongoing Phase 2 Clinical Trials  \\\n",
       "0                                      24   \n",
       "1                                      18   \n",
       "2                                      34   \n",
       "3                                      29   \n",
       "4                                       6   \n",
       "\n",
       "   No. of Ongoing Phase 3 Clinical Trials  Filed  Total in Pipeline  \\\n",
       "0                                      39     11                 99   \n",
       "1                                      36      4                 84   \n",
       "2                                      28      8                104   \n",
       "3                                      52     32                178   \n",
       "4                                      13      2                 30   \n",
       "\n",
       "   Total Approved Treatments on the Market in the U.S.A.   No. of Employees  \n",
       "0                                                 67                 141700  \n",
       "1                                                 46                  35000  \n",
       "2                                                314                  79000  \n",
       "3                                                 47                 100920  \n",
       "4                                                 22                  50816  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "bdb5fe26-578f-415b-8f98-ef97b9a1a314",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8ef37725-f591-4844-801c-c675af609927",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>Company Age</th>\n",
       "      <th>Est. Market Capitalization</th>\n",
       "      <th>Total Liabilities</th>\n",
       "      <th>D/E Ratio</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2021</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2020</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2019</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2018</th>\n",
       "      <th>Number of Research Areas Covered by R&amp;D Pipeline</th>\n",
       "      <th>No. of Ongoing Phase 1 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 2 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 3 Clinical Trials</th>\n",
       "      <th>Filed</th>\n",
       "      <th>Total in Pipeline</th>\n",
       "      <th>Total Approved Treatments on the Market in the U.S.A.</th>\n",
       "      <th>No. of Employees</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>20.00000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.00000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>10.50000</td>\n",
       "      <td>75.500000</td>\n",
       "      <td>1.686825e+11</td>\n",
       "      <td>5.790276e+10</td>\n",
       "      <td>0.378619</td>\n",
       "      <td>1974.507500</td>\n",
       "      <td>1819.932500</td>\n",
       "      <td>1507.632500</td>\n",
       "      <td>1499.995000</td>\n",
       "      <td>6.300000</td>\n",
       "      <td>25.250000</td>\n",
       "      <td>24.050000</td>\n",
       "      <td>24.85000</td>\n",
       "      <td>5.300000</td>\n",
       "      <td>79.450000</td>\n",
       "      <td>53.300000</td>\n",
       "      <td>56347.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>5.91608</td>\n",
       "      <td>57.533057</td>\n",
       "      <td>1.053691e+11</td>\n",
       "      <td>4.053955e+10</td>\n",
       "      <td>0.337010</td>\n",
       "      <td>1222.258865</td>\n",
       "      <td>1176.431315</td>\n",
       "      <td>960.776681</td>\n",
       "      <td>1002.138337</td>\n",
       "      <td>2.154555</td>\n",
       "      <td>18.327072</td>\n",
       "      <td>19.126931</td>\n",
       "      <td>16.08947</td>\n",
       "      <td>7.197222</td>\n",
       "      <td>46.497849</td>\n",
       "      <td>67.919534</td>\n",
       "      <td>40822.230398</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>1.00000</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>4.927000e+10</td>\n",
       "      <td>3.648700e+09</td>\n",
       "      <td>0.049534</td>\n",
       "      <td>250.250000</td>\n",
       "      <td>230.500000</td>\n",
       "      <td>119.000000</td>\n",
       "      <td>109.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>4.00000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>13.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>3400.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>5.75000</td>\n",
       "      <td>25.250000</td>\n",
       "      <td>7.638000e+10</td>\n",
       "      <td>3.081780e+10</td>\n",
       "      <td>0.131318</td>\n",
       "      <td>1026.500000</td>\n",
       "      <td>967.500000</td>\n",
       "      <td>889.500000</td>\n",
       "      <td>833.750000</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>16.000000</td>\n",
       "      <td>10.250000</td>\n",
       "      <td>11.75000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>40.500000</td>\n",
       "      <td>21.500000</td>\n",
       "      <td>22264.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>10.50000</td>\n",
       "      <td>45.500000</td>\n",
       "      <td>1.428100e+11</td>\n",
       "      <td>5.884700e+10</td>\n",
       "      <td>0.316177</td>\n",
       "      <td>1807.500000</td>\n",
       "      <td>1492.000000</td>\n",
       "      <td>1402.450000</td>\n",
       "      <td>1283.950000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>19.000000</td>\n",
       "      <td>19.500000</td>\n",
       "      <td>23.50000</td>\n",
       "      <td>3.500000</td>\n",
       "      <td>77.500000</td>\n",
       "      <td>34.000000</td>\n",
       "      <td>50408.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>15.25000</td>\n",
       "      <td>132.000000</td>\n",
       "      <td>2.447850e+11</td>\n",
       "      <td>7.167825e+10</td>\n",
       "      <td>0.461405</td>\n",
       "      <td>2646.500000</td>\n",
       "      <td>2584.250000</td>\n",
       "      <td>2191.500000</td>\n",
       "      <td>2178.750000</td>\n",
       "      <td>7.000000</td>\n",
       "      <td>33.250000</td>\n",
       "      <td>34.250000</td>\n",
       "      <td>36.25000</td>\n",
       "      <td>4.750000</td>\n",
       "      <td>108.250000</td>\n",
       "      <td>65.500000</td>\n",
       "      <td>91432.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>20.00000</td>\n",
       "      <td>173.000000</td>\n",
       "      <td>4.498700e+11</td>\n",
       "      <td>1.444760e+11</td>\n",
       "      <td>1.538355</td>\n",
       "      <td>4443.000000</td>\n",
       "      <td>3936.000000</td>\n",
       "      <td>3555.000000</td>\n",
       "      <td>3701.250000</td>\n",
       "      <td>11.000000</td>\n",
       "      <td>69.000000</td>\n",
       "      <td>77.000000</td>\n",
       "      <td>57.00000</td>\n",
       "      <td>32.000000</td>\n",
       "      <td>178.000000</td>\n",
       "      <td>314.000000</td>\n",
       "      <td>141700.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           Rank  Company Age  Est. Market Capitalization  Total Liabilities  \\\n",
       "count  20.00000    20.000000                2.000000e+01       2.000000e+01   \n",
       "mean   10.50000    75.500000                1.686825e+11       5.790276e+10   \n",
       "std     5.91608    57.533057                1.053691e+11       4.053955e+10   \n",
       "min     1.00000     9.000000                4.927000e+10       3.648700e+09   \n",
       "25%     5.75000    25.250000                7.638000e+10       3.081780e+10   \n",
       "50%    10.50000    45.500000                1.428100e+11       5.884700e+10   \n",
       "75%    15.25000   132.000000                2.447850e+11       7.167825e+10   \n",
       "max    20.00000   173.000000                4.498700e+11       1.444760e+11   \n",
       "\n",
       "       D/E Ratio  R&D Expense 3rd Quarter 2021  R&D Expense 3rd Quarter 2020  \\\n",
       "count  20.000000                     20.000000                     20.000000   \n",
       "mean    0.378619                   1974.507500                   1819.932500   \n",
       "std     0.337010                   1222.258865                   1176.431315   \n",
       "min     0.049534                    250.250000                    230.500000   \n",
       "25%     0.131318                   1026.500000                    967.500000   \n",
       "50%     0.316177                   1807.500000                   1492.000000   \n",
       "75%     0.461405                   2646.500000                   2584.250000   \n",
       "max     1.538355                   4443.000000                   3936.000000   \n",
       "\n",
       "       R&D Expense 3rd Quarter 2019  R&D Expense 3rd Quarter 2018  \\\n",
       "count                     20.000000                     20.000000   \n",
       "mean                    1507.632500                   1499.995000   \n",
       "std                      960.776681                   1002.138337   \n",
       "min                      119.000000                    109.000000   \n",
       "25%                      889.500000                    833.750000   \n",
       "50%                     1402.450000                   1283.950000   \n",
       "75%                     2191.500000                   2178.750000   \n",
       "max                     3555.000000                   3701.250000   \n",
       "\n",
       "       Number of Research Areas Covered by R&D Pipeline  \\\n",
       "count                                         20.000000   \n",
       "mean                                           6.300000   \n",
       "std                                            2.154555   \n",
       "min                                            3.000000   \n",
       "25%                                            5.000000   \n",
       "50%                                            6.000000   \n",
       "75%                                            7.000000   \n",
       "max                                           11.000000   \n",
       "\n",
       "       No. of Ongoing Phase 1 Clinical Trials  \\\n",
       "count                               20.000000   \n",
       "mean                                25.250000   \n",
       "std                                 18.327072   \n",
       "min                                  0.000000   \n",
       "25%                                 16.000000   \n",
       "50%                                 19.000000   \n",
       "75%                                 33.250000   \n",
       "max                                 69.000000   \n",
       "\n",
       "       No. of Ongoing Phase 2 Clinical Trials  \\\n",
       "count                               20.000000   \n",
       "mean                                24.050000   \n",
       "std                                 19.126931   \n",
       "min                                  3.000000   \n",
       "25%                                 10.250000   \n",
       "50%                                 19.500000   \n",
       "75%                                 34.250000   \n",
       "max                                 77.000000   \n",
       "\n",
       "       No. of Ongoing Phase 3 Clinical Trials      Filed  Total in Pipeline  \\\n",
       "count                                20.00000  20.000000          20.000000   \n",
       "mean                                 24.85000   5.300000          79.450000   \n",
       "std                                  16.08947   7.197222          46.497849   \n",
       "min                                   4.00000   0.000000          13.000000   \n",
       "25%                                  11.75000   2.000000          40.500000   \n",
       "50%                                  23.50000   3.500000          77.500000   \n",
       "75%                                  36.25000   4.750000         108.250000   \n",
       "max                                  57.00000  32.000000         178.000000   \n",
       "\n",
       "       Total Approved Treatments on the Market in the U.S.A.   \\\n",
       "count                                          20.000000        \n",
       "mean                                           53.300000        \n",
       "std                                            67.919534        \n",
       "min                                             1.000000        \n",
       "25%                                            21.500000        \n",
       "50%                                            34.000000        \n",
       "75%                                            65.500000        \n",
       "max                                           314.000000        \n",
       "\n",
       "       No. of Employees  \n",
       "count         20.000000  \n",
       "mean       56347.500000  \n",
       "std        40822.230398  \n",
       "min         3400.000000  \n",
       "25%        22264.500000  \n",
       "50%        50408.000000  \n",
       "75%        91432.500000  \n",
       "max       141700.000000  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "9fe39149-64b0-4e4f-92b0-b117cf3d8f43",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "58953f46-78fc-4f69-8866-5590511d00ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([6., 5., 4., 3., 0., 1., 0., 0., 0., 1.]),\n",
       " array([0.04953435, 0.19841645, 0.34729856, 0.49618067, 0.64506277,\n",
       "        0.79394488, 0.94282698, 1.09170909, 1.2405912 , 1.3894733 ,\n",
       "        1.53835541]),\n",
       " <BarContainer object of 10 artists>)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(df['D/E Ratio'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "ed60751e-e077-4691-8f74-1eddb3a4ef0f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([9., 5., 3., 2., 0., 0., 0., 0., 0., 1.]),\n",
       " array([  1. ,  32.3,  63.6,  94.9, 126.2, 157.5, 188.8, 220.1, 251.4,\n",
       "        282.7, 314. ]),\n",
       " <BarContainer object of 10 artists>)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(df['Total Approved Treatments on the Market in the U.S.A. '])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "85646c8b-48e3-4d81-b995-bbb952f17922",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Company Age</th>\n",
       "      <th>Est. Market Capitalization</th>\n",
       "      <th>Total Liabilities</th>\n",
       "      <th>D/E Ratio</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2020</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2019</th>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2018</th>\n",
       "      <th>Number of Research Areas Covered by R&amp;D Pipeline</th>\n",
       "      <th>No. of Ongoing Phase 1 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 2 Clinical Trials</th>\n",
       "      <th>No. of Ongoing Phase 3 Clinical Trials</th>\n",
       "      <th>Filed</th>\n",
       "      <th>Total in Pipeline</th>\n",
       "      <th>Total Approved Treatments on the Market in the U.S.A.</th>\n",
       "      <th>No. of Employees</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Company Age</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.495697</td>\n",
       "      <td>0.333965</td>\n",
       "      <td>0.205140</td>\n",
       "      <td>0.489173</td>\n",
       "      <td>0.296671</td>\n",
       "      <td>0.274445</td>\n",
       "      <td>0.036090</td>\n",
       "      <td>0.021039</td>\n",
       "      <td>0.208459</td>\n",
       "      <td>0.148767</td>\n",
       "      <td>0.291961</td>\n",
       "      <td>0.190711</td>\n",
       "      <td>0.441297</td>\n",
       "      <td>0.352864</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Est. Market Capitalization</th>\n",
       "      <td>0.495697</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.631429</td>\n",
       "      <td>-0.176778</td>\n",
       "      <td>0.493748</td>\n",
       "      <td>0.699426</td>\n",
       "      <td>0.705013</td>\n",
       "      <td>0.276708</td>\n",
       "      <td>0.167628</td>\n",
       "      <td>0.316451</td>\n",
       "      <td>0.476235</td>\n",
       "      <td>0.322086</td>\n",
       "      <td>0.410887</td>\n",
       "      <td>0.409622</td>\n",
       "      <td>0.571457</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total Liabilities</th>\n",
       "      <td>0.333965</td>\n",
       "      <td>0.631429</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.493702</td>\n",
       "      <td>0.699063</td>\n",
       "      <td>0.731571</td>\n",
       "      <td>0.815119</td>\n",
       "      <td>0.310170</td>\n",
       "      <td>0.223031</td>\n",
       "      <td>0.212447</td>\n",
       "      <td>0.298254</td>\n",
       "      <td>-0.026795</td>\n",
       "      <td>0.274354</td>\n",
       "      <td>0.365896</td>\n",
       "      <td>0.555448</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>D/E Ratio</th>\n",
       "      <td>0.205140</td>\n",
       "      <td>-0.176778</td>\n",
       "      <td>0.493702</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.531031</td>\n",
       "      <td>0.205227</td>\n",
       "      <td>0.218678</td>\n",
       "      <td>-0.188249</td>\n",
       "      <td>0.183419</td>\n",
       "      <td>-0.028646</td>\n",
       "      <td>0.048713</td>\n",
       "      <td>-0.246438</td>\n",
       "      <td>0.039222</td>\n",
       "      <td>0.027740</td>\n",
       "      <td>0.353710</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2020</th>\n",
       "      <td>0.489173</td>\n",
       "      <td>0.493748</td>\n",
       "      <td>0.699063</td>\n",
       "      <td>0.531031</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.851395</td>\n",
       "      <td>0.817168</td>\n",
       "      <td>0.075682</td>\n",
       "      <td>0.312531</td>\n",
       "      <td>0.491249</td>\n",
       "      <td>0.398837</td>\n",
       "      <td>0.200385</td>\n",
       "      <td>0.494284</td>\n",
       "      <td>0.290290</td>\n",
       "      <td>0.641077</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2019</th>\n",
       "      <td>0.296671</td>\n",
       "      <td>0.699426</td>\n",
       "      <td>0.731571</td>\n",
       "      <td>0.205227</td>\n",
       "      <td>0.851395</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.965798</td>\n",
       "      <td>0.184182</td>\n",
       "      <td>0.480884</td>\n",
       "      <td>0.488423</td>\n",
       "      <td>0.604308</td>\n",
       "      <td>0.413363</td>\n",
       "      <td>0.663542</td>\n",
       "      <td>0.413768</td>\n",
       "      <td>0.682598</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2018</th>\n",
       "      <td>0.274445</td>\n",
       "      <td>0.705013</td>\n",
       "      <td>0.815119</td>\n",
       "      <td>0.218678</td>\n",
       "      <td>0.817168</td>\n",
       "      <td>0.965798</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.324483</td>\n",
       "      <td>0.357459</td>\n",
       "      <td>0.436078</td>\n",
       "      <td>0.508579</td>\n",
       "      <td>0.334776</td>\n",
       "      <td>0.548073</td>\n",
       "      <td>0.333571</td>\n",
       "      <td>0.637923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Number of Research Areas Covered by R&amp;D Pipeline</th>\n",
       "      <td>0.036090</td>\n",
       "      <td>0.276708</td>\n",
       "      <td>0.310170</td>\n",
       "      <td>-0.188249</td>\n",
       "      <td>0.075682</td>\n",
       "      <td>0.184182</td>\n",
       "      <td>0.324483</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>-0.075309</td>\n",
       "      <td>0.118392</td>\n",
       "      <td>0.066652</td>\n",
       "      <td>0.004073</td>\n",
       "      <td>0.042712</td>\n",
       "      <td>0.033880</td>\n",
       "      <td>0.082190</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>No. of Ongoing Phase 1 Clinical Trials</th>\n",
       "      <td>0.021039</td>\n",
       "      <td>0.167628</td>\n",
       "      <td>0.223031</td>\n",
       "      <td>0.183419</td>\n",
       "      <td>0.312531</td>\n",
       "      <td>0.480884</td>\n",
       "      <td>0.357459</td>\n",
       "      <td>-0.075309</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.161818</td>\n",
       "      <td>0.792268</td>\n",
       "      <td>0.467844</td>\n",
       "      <td>0.807274</td>\n",
       "      <td>0.228642</td>\n",
       "      <td>0.450552</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>No. of Ongoing Phase 2 Clinical Trials</th>\n",
       "      <td>0.208459</td>\n",
       "      <td>0.316451</td>\n",
       "      <td>0.212447</td>\n",
       "      <td>-0.028646</td>\n",
       "      <td>0.491249</td>\n",
       "      <td>0.488423</td>\n",
       "      <td>0.436078</td>\n",
       "      <td>0.118392</td>\n",
       "      <td>0.161818</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.538070</td>\n",
       "      <td>0.030089</td>\n",
       "      <td>0.665975</td>\n",
       "      <td>0.466265</td>\n",
       "      <td>0.465012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>No. of Ongoing Phase 3 Clinical Trials</th>\n",
       "      <td>0.148767</td>\n",
       "      <td>0.476235</td>\n",
       "      <td>0.298254</td>\n",
       "      <td>0.048713</td>\n",
       "      <td>0.398837</td>\n",
       "      <td>0.604308</td>\n",
       "      <td>0.508579</td>\n",
       "      <td>0.066652</td>\n",
       "      <td>0.792268</td>\n",
       "      <td>0.538070</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.458097</td>\n",
       "      <td>0.950540</td>\n",
       "      <td>0.367957</td>\n",
       "      <td>0.722252</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Filed</th>\n",
       "      <td>0.291961</td>\n",
       "      <td>0.322086</td>\n",
       "      <td>-0.026795</td>\n",
       "      <td>-0.246438</td>\n",
       "      <td>0.200385</td>\n",
       "      <td>0.413363</td>\n",
       "      <td>0.334776</td>\n",
       "      <td>0.004073</td>\n",
       "      <td>0.467844</td>\n",
       "      <td>0.030089</td>\n",
       "      <td>0.458097</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.510077</td>\n",
       "      <td>0.146342</td>\n",
       "      <td>0.381402</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total in Pipeline</th>\n",
       "      <td>0.190711</td>\n",
       "      <td>0.410887</td>\n",
       "      <td>0.274354</td>\n",
       "      <td>0.039222</td>\n",
       "      <td>0.494284</td>\n",
       "      <td>0.663542</td>\n",
       "      <td>0.548073</td>\n",
       "      <td>0.042712</td>\n",
       "      <td>0.807274</td>\n",
       "      <td>0.665975</td>\n",
       "      <td>0.950540</td>\n",
       "      <td>0.510077</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.431892</td>\n",
       "      <td>0.677821</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total Approved Treatments on the Market in the U.S.A.</th>\n",
       "      <td>0.441297</td>\n",
       "      <td>0.409622</td>\n",
       "      <td>0.365896</td>\n",
       "      <td>0.027740</td>\n",
       "      <td>0.290290</td>\n",
       "      <td>0.413768</td>\n",
       "      <td>0.333571</td>\n",
       "      <td>0.033880</td>\n",
       "      <td>0.228642</td>\n",
       "      <td>0.466265</td>\n",
       "      <td>0.367957</td>\n",
       "      <td>0.146342</td>\n",
       "      <td>0.431892</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.431529</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>No. of Employees</th>\n",
       "      <td>0.352864</td>\n",
       "      <td>0.571457</td>\n",
       "      <td>0.555448</td>\n",
       "      <td>0.353710</td>\n",
       "      <td>0.641077</td>\n",
       "      <td>0.682598</td>\n",
       "      <td>0.637923</td>\n",
       "      <td>0.082190</td>\n",
       "      <td>0.450552</td>\n",
       "      <td>0.465012</td>\n",
       "      <td>0.722252</td>\n",
       "      <td>0.381402</td>\n",
       "      <td>0.677821</td>\n",
       "      <td>0.431529</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Company Age  \\\n",
       "Company Age                                            1.000000   \n",
       "Est. Market Capitalization                             0.495697   \n",
       "Total Liabilities                                      0.333965   \n",
       "D/E Ratio                                              0.205140   \n",
       "R&D Expense 3rd Quarter 2020                           0.489173   \n",
       "R&D Expense 3rd Quarter 2019                           0.296671   \n",
       "R&D Expense 3rd Quarter 2018                           0.274445   \n",
       "Number of Research Areas Covered by R&D Pipeline       0.036090   \n",
       "No. of Ongoing Phase 1 Clinical Trials                 0.021039   \n",
       "No. of Ongoing Phase 2 Clinical Trials                 0.208459   \n",
       "No. of Ongoing Phase 3 Clinical Trials                 0.148767   \n",
       "Filed                                                  0.291961   \n",
       "Total in Pipeline                                      0.190711   \n",
       "Total Approved Treatments on the Market in the ...     0.441297   \n",
       "No. of Employees                                       0.352864   \n",
       "\n",
       "                                                    Est. Market Capitalization  \\\n",
       "Company Age                                                           0.495697   \n",
       "Est. Market Capitalization                                            1.000000   \n",
       "Total Liabilities                                                     0.631429   \n",
       "D/E Ratio                                                            -0.176778   \n",
       "R&D Expense 3rd Quarter 2020                                          0.493748   \n",
       "R&D Expense 3rd Quarter 2019                                          0.699426   \n",
       "R&D Expense 3rd Quarter 2018                                          0.705013   \n",
       "Number of Research Areas Covered by R&D Pipeline                      0.276708   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                0.167628   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                0.316451   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                0.476235   \n",
       "Filed                                                                 0.322086   \n",
       "Total in Pipeline                                                     0.410887   \n",
       "Total Approved Treatments on the Market in the ...                    0.409622   \n",
       "No. of Employees                                                      0.571457   \n",
       "\n",
       "                                                    Total Liabilities  \\\n",
       "Company Age                                                  0.333965   \n",
       "Est. Market Capitalization                                   0.631429   \n",
       "Total Liabilities                                            1.000000   \n",
       "D/E Ratio                                                    0.493702   \n",
       "R&D Expense 3rd Quarter 2020                                 0.699063   \n",
       "R&D Expense 3rd Quarter 2019                                 0.731571   \n",
       "R&D Expense 3rd Quarter 2018                                 0.815119   \n",
       "Number of Research Areas Covered by R&D Pipeline             0.310170   \n",
       "No. of Ongoing Phase 1 Clinical Trials                       0.223031   \n",
       "No. of Ongoing Phase 2 Clinical Trials                       0.212447   \n",
       "No. of Ongoing Phase 3 Clinical Trials                       0.298254   \n",
       "Filed                                                       -0.026795   \n",
       "Total in Pipeline                                            0.274354   \n",
       "Total Approved Treatments on the Market in the ...           0.365896   \n",
       "No. of Employees                                             0.555448   \n",
       "\n",
       "                                                    D/E Ratio  \\\n",
       "Company Age                                          0.205140   \n",
       "Est. Market Capitalization                          -0.176778   \n",
       "Total Liabilities                                    0.493702   \n",
       "D/E Ratio                                            1.000000   \n",
       "R&D Expense 3rd Quarter 2020                         0.531031   \n",
       "R&D Expense 3rd Quarter 2019                         0.205227   \n",
       "R&D Expense 3rd Quarter 2018                         0.218678   \n",
       "Number of Research Areas Covered by R&D Pipeline    -0.188249   \n",
       "No. of Ongoing Phase 1 Clinical Trials               0.183419   \n",
       "No. of Ongoing Phase 2 Clinical Trials              -0.028646   \n",
       "No. of Ongoing Phase 3 Clinical Trials               0.048713   \n",
       "Filed                                               -0.246438   \n",
       "Total in Pipeline                                    0.039222   \n",
       "Total Approved Treatments on the Market in the ...   0.027740   \n",
       "No. of Employees                                     0.353710   \n",
       "\n",
       "                                                    R&D Expense 3rd Quarter 2020  \\\n",
       "Company Age                                                             0.489173   \n",
       "Est. Market Capitalization                                              0.493748   \n",
       "Total Liabilities                                                       0.699063   \n",
       "D/E Ratio                                                               0.531031   \n",
       "R&D Expense 3rd Quarter 2020                                            1.000000   \n",
       "R&D Expense 3rd Quarter 2019                                            0.851395   \n",
       "R&D Expense 3rd Quarter 2018                                            0.817168   \n",
       "Number of Research Areas Covered by R&D Pipeline                        0.075682   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                  0.312531   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                  0.491249   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                  0.398837   \n",
       "Filed                                                                   0.200385   \n",
       "Total in Pipeline                                                       0.494284   \n",
       "Total Approved Treatments on the Market in the ...                      0.290290   \n",
       "No. of Employees                                                        0.641077   \n",
       "\n",
       "                                                    R&D Expense 3rd Quarter 2019  \\\n",
       "Company Age                                                             0.296671   \n",
       "Est. Market Capitalization                                              0.699426   \n",
       "Total Liabilities                                                       0.731571   \n",
       "D/E Ratio                                                               0.205227   \n",
       "R&D Expense 3rd Quarter 2020                                            0.851395   \n",
       "R&D Expense 3rd Quarter 2019                                            1.000000   \n",
       "R&D Expense 3rd Quarter 2018                                            0.965798   \n",
       "Number of Research Areas Covered by R&D Pipeline                        0.184182   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                  0.480884   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                  0.488423   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                  0.604308   \n",
       "Filed                                                                   0.413363   \n",
       "Total in Pipeline                                                       0.663542   \n",
       "Total Approved Treatments on the Market in the ...                      0.413768   \n",
       "No. of Employees                                                        0.682598   \n",
       "\n",
       "                                                    R&D Expense 3rd Quarter 2018  \\\n",
       "Company Age                                                             0.274445   \n",
       "Est. Market Capitalization                                              0.705013   \n",
       "Total Liabilities                                                       0.815119   \n",
       "D/E Ratio                                                               0.218678   \n",
       "R&D Expense 3rd Quarter 2020                                            0.817168   \n",
       "R&D Expense 3rd Quarter 2019                                            0.965798   \n",
       "R&D Expense 3rd Quarter 2018                                            1.000000   \n",
       "Number of Research Areas Covered by R&D Pipeline                        0.324483   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                  0.357459   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                  0.436078   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                  0.508579   \n",
       "Filed                                                                   0.334776   \n",
       "Total in Pipeline                                                       0.548073   \n",
       "Total Approved Treatments on the Market in the ...                      0.333571   \n",
       "No. of Employees                                                        0.637923   \n",
       "\n",
       "                                                    Number of Research Areas Covered by R&D Pipeline  \\\n",
       "Company Age                                                                                 0.036090   \n",
       "Est. Market Capitalization                                                                  0.276708   \n",
       "Total Liabilities                                                                           0.310170   \n",
       "D/E Ratio                                                                                  -0.188249   \n",
       "R&D Expense 3rd Quarter 2020                                                                0.075682   \n",
       "R&D Expense 3rd Quarter 2019                                                                0.184182   \n",
       "R&D Expense 3rd Quarter 2018                                                                0.324483   \n",
       "Number of Research Areas Covered by R&D Pipeline                                            1.000000   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                                     -0.075309   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                                      0.118392   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                                      0.066652   \n",
       "Filed                                                                                       0.004073   \n",
       "Total in Pipeline                                                                           0.042712   \n",
       "Total Approved Treatments on the Market in the ...                                          0.033880   \n",
       "No. of Employees                                                                            0.082190   \n",
       "\n",
       "                                                    No. of Ongoing Phase 1 Clinical Trials  \\\n",
       "Company Age                                                                       0.021039   \n",
       "Est. Market Capitalization                                                        0.167628   \n",
       "Total Liabilities                                                                 0.223031   \n",
       "D/E Ratio                                                                         0.183419   \n",
       "R&D Expense 3rd Quarter 2020                                                      0.312531   \n",
       "R&D Expense 3rd Quarter 2019                                                      0.480884   \n",
       "R&D Expense 3rd Quarter 2018                                                      0.357459   \n",
       "Number of Research Areas Covered by R&D Pipeline                                 -0.075309   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                            1.000000   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                            0.161818   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                            0.792268   \n",
       "Filed                                                                             0.467844   \n",
       "Total in Pipeline                                                                 0.807274   \n",
       "Total Approved Treatments on the Market in the ...                                0.228642   \n",
       "No. of Employees                                                                  0.450552   \n",
       "\n",
       "                                                    No. of Ongoing Phase 2 Clinical Trials  \\\n",
       "Company Age                                                                       0.208459   \n",
       "Est. Market Capitalization                                                        0.316451   \n",
       "Total Liabilities                                                                 0.212447   \n",
       "D/E Ratio                                                                        -0.028646   \n",
       "R&D Expense 3rd Quarter 2020                                                      0.491249   \n",
       "R&D Expense 3rd Quarter 2019                                                      0.488423   \n",
       "R&D Expense 3rd Quarter 2018                                                      0.436078   \n",
       "Number of Research Areas Covered by R&D Pipeline                                  0.118392   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                            0.161818   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                            1.000000   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                            0.538070   \n",
       "Filed                                                                             0.030089   \n",
       "Total in Pipeline                                                                 0.665975   \n",
       "Total Approved Treatments on the Market in the ...                                0.466265   \n",
       "No. of Employees                                                                  0.465012   \n",
       "\n",
       "                                                    No. of Ongoing Phase 3 Clinical Trials  \\\n",
       "Company Age                                                                       0.148767   \n",
       "Est. Market Capitalization                                                        0.476235   \n",
       "Total Liabilities                                                                 0.298254   \n",
       "D/E Ratio                                                                         0.048713   \n",
       "R&D Expense 3rd Quarter 2020                                                      0.398837   \n",
       "R&D Expense 3rd Quarter 2019                                                      0.604308   \n",
       "R&D Expense 3rd Quarter 2018                                                      0.508579   \n",
       "Number of Research Areas Covered by R&D Pipeline                                  0.066652   \n",
       "No. of Ongoing Phase 1 Clinical Trials                                            0.792268   \n",
       "No. of Ongoing Phase 2 Clinical Trials                                            0.538070   \n",
       "No. of Ongoing Phase 3 Clinical Trials                                            1.000000   \n",
       "Filed                                                                             0.458097   \n",
       "Total in Pipeline                                                                 0.950540   \n",
       "Total Approved Treatments on the Market in the ...                                0.367957   \n",
       "No. of Employees                                                                  0.722252   \n",
       "\n",
       "                                                       Filed  \\\n",
       "Company Age                                         0.291961   \n",
       "Est. Market Capitalization                          0.322086   \n",
       "Total Liabilities                                  -0.026795   \n",
       "D/E Ratio                                          -0.246438   \n",
       "R&D Expense 3rd Quarter 2020                        0.200385   \n",
       "R&D Expense 3rd Quarter 2019                        0.413363   \n",
       "R&D Expense 3rd Quarter 2018                        0.334776   \n",
       "Number of Research Areas Covered by R&D Pipeline    0.004073   \n",
       "No. of Ongoing Phase 1 Clinical Trials              0.467844   \n",
       "No. of Ongoing Phase 2 Clinical Trials              0.030089   \n",
       "No. of Ongoing Phase 3 Clinical Trials              0.458097   \n",
       "Filed                                               1.000000   \n",
       "Total in Pipeline                                   0.510077   \n",
       "Total Approved Treatments on the Market in the ...  0.146342   \n",
       "No. of Employees                                    0.381402   \n",
       "\n",
       "                                                    Total in Pipeline  \\\n",
       "Company Age                                                  0.190711   \n",
       "Est. Market Capitalization                                   0.410887   \n",
       "Total Liabilities                                            0.274354   \n",
       "D/E Ratio                                                    0.039222   \n",
       "R&D Expense 3rd Quarter 2020                                 0.494284   \n",
       "R&D Expense 3rd Quarter 2019                                 0.663542   \n",
       "R&D Expense 3rd Quarter 2018                                 0.548073   \n",
       "Number of Research Areas Covered by R&D Pipeline             0.042712   \n",
       "No. of Ongoing Phase 1 Clinical Trials                       0.807274   \n",
       "No. of Ongoing Phase 2 Clinical Trials                       0.665975   \n",
       "No. of Ongoing Phase 3 Clinical Trials                       0.950540   \n",
       "Filed                                                        0.510077   \n",
       "Total in Pipeline                                            1.000000   \n",
       "Total Approved Treatments on the Market in the ...           0.431892   \n",
       "No. of Employees                                             0.677821   \n",
       "\n",
       "                                                    Total Approved Treatments on the Market in the U.S.A.   \\\n",
       "Company Age                                                                                  0.441297        \n",
       "Est. Market Capitalization                                                                   0.409622        \n",
       "Total Liabilities                                                                            0.365896        \n",
       "D/E Ratio                                                                                    0.027740        \n",
       "R&D Expense 3rd Quarter 2020                                                                 0.290290        \n",
       "R&D Expense 3rd Quarter 2019                                                                 0.413768        \n",
       "R&D Expense 3rd Quarter 2018                                                                 0.333571        \n",
       "Number of Research Areas Covered by R&D Pipeline                                             0.033880        \n",
       "No. of Ongoing Phase 1 Clinical Trials                                                       0.228642        \n",
       "No. of Ongoing Phase 2 Clinical Trials                                                       0.466265        \n",
       "No. of Ongoing Phase 3 Clinical Trials                                                       0.367957        \n",
       "Filed                                                                                        0.146342        \n",
       "Total in Pipeline                                                                            0.431892        \n",
       "Total Approved Treatments on the Market in the ...                                           1.000000        \n",
       "No. of Employees                                                                             0.431529        \n",
       "\n",
       "                                                    No. of Employees  \n",
       "Company Age                                                 0.352864  \n",
       "Est. Market Capitalization                                  0.571457  \n",
       "Total Liabilities                                           0.555448  \n",
       "D/E Ratio                                                   0.353710  \n",
       "R&D Expense 3rd Quarter 2020                                0.641077  \n",
       "R&D Expense 3rd Quarter 2019                                0.682598  \n",
       "R&D Expense 3rd Quarter 2018                                0.637923  \n",
       "Number of Research Areas Covered by R&D Pipeline            0.082190  \n",
       "No. of Ongoing Phase 1 Clinical Trials                      0.450552  \n",
       "No. of Ongoing Phase 2 Clinical Trials                      0.465012  \n",
       "No. of Ongoing Phase 3 Clinical Trials                      0.722252  \n",
       "Filed                                                       0.381402  \n",
       "Total in Pipeline                                           0.677821  \n",
       "Total Approved Treatments on the Market in the ...          0.431529  \n",
       "No. of Employees                                            1.000000  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[['Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
    "       'D/E Ratio', 'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
    "       'R&D Expense 3rd Quarter 2018', 'Number of Research Areas Covered by R&D Pipeline',\n",
    "       'No. of Ongoing Phase 1 Clinical Trials',\n",
    "       'No. of Ongoing Phase 2 Clinical Trials',\n",
    "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
    "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
    "       'No. of Employees']].corr()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "e6f19272-b8ce-4841-a685-8c8c1999fe7c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:>"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "cmap = sns.diverging_palette(220, 10, as_cmap=True)\n",
    "sns.heatmap(df[['Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
    "       'D/E Ratio', 'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
    "       'R&D Expense 3rd Quarter 2018', 'Number of Research Areas Covered by R&D Pipeline',\n",
    "       'No. of Ongoing Phase 1 Clinical Trials',\n",
    "       'No. of Ongoing Phase 2 Clinical Trials',\n",
    "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
    "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
    "       'No. of Employees']].corr(), vmax=.3, center=0, cmap=cmap, square=True, linewidth=.5, cbar_kws={\"shrink\": .5})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "312fbcc5-1729-4c74-8c26-4f5f2b9c0040",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "eb1ec4e8-f50a-4c48-bd99-2186b62b584e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_cat = df[['Company Name ', 'Ticker Symbol', 'Country of Origin', 'No. of Employees','Total Approved Treatments on the Market in the U.S.A. ']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "0d8f5665-427e-4d7f-9953-4a0945a38d82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "graph for Company Name : total = 20\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "graph for Ticker Symbol: total = 20\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "graph for Country of Origin: total = 8\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "graph for No. of Employees: total = 20\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "graph for Total Approved Treatments on the Market in the U.S.A. : total = 19\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "for i in df_cat.columns:\n",
    "    cat_num = df_cat[i].value_counts()\n",
    "    print(\"graph for %s: total = %d\" % (i, len(cat_num)))\n",
    "    chart = sns.barplot(x=cat_num.index, y=cat_num)\n",
    "    chart.set_xticklabels(chart.get_xticklabels(), rotation=90)\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "b25b8122-1087-4d50-9c45-4b3d2ee0a21a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "b263c5eb-d5b4-44f0-8e51-57c3b0b00cda",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>D/E Ratio</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Company Name</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>AbbVie</th>\n",
       "      <td>0.526782</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amgen</th>\n",
       "      <td>0.432082</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Astrazeneca</th>\n",
       "      <td>0.312355</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bayer</th>\n",
       "      <td>1.538355</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bristol-Myers Squibb</th>\n",
       "      <td>0.439613</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CSL</th>\n",
       "      <td>0.058800</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Daiichi Sankyo</th>\n",
       "      <td>0.130853</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Eli Lilly</th>\n",
       "      <td>0.131472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gilead Sciences</th>\n",
       "      <td>0.560075</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GlaxoSmithKline</th>\n",
       "      <td>0.797179</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Johnson &amp; Johnson</th>\n",
       "      <td>0.225325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Merck</th>\n",
       "      <td>0.285906</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Moderna</th>\n",
       "      <td>0.108438</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novartis</th>\n",
       "      <td>0.320000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novo Nordisk</th>\n",
       "      <td>0.551288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pfizer</th>\n",
       "      <td>0.365920</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Regeneron Pharmaceuticals</th>\n",
       "      <td>0.098340</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Roche</th>\n",
       "      <td>0.233637</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sanofi</th>\n",
       "      <td>0.406419</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Vertex Pharmaceuticals</th>\n",
       "      <td>0.049534</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           D/E Ratio\n",
       "Company Name                        \n",
       "AbbVie                      0.526782\n",
       "Amgen                       0.432082\n",
       "Astrazeneca                 0.312355\n",
       "Bayer                       1.538355\n",
       "Bristol-Myers Squibb        0.439613\n",
       "CSL                         0.058800\n",
       "Daiichi Sankyo              0.130853\n",
       "Eli Lilly                   0.131472\n",
       "Gilead Sciences             0.560075\n",
       "GlaxoSmithKline             0.797179\n",
       "Johnson & Johnson           0.225325\n",
       "Merck                       0.285906\n",
       "Moderna                     0.108438\n",
       "Novartis                    0.320000\n",
       "Novo Nordisk                0.551288\n",
       "Pfizer                      0.365920\n",
       "Regeneron Pharmaceuticals   0.098340\n",
       "Roche                       0.233637\n",
       "Sanofi                      0.406419\n",
       "Vertex Pharmaceuticals      0.049534"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.pivot_table(df, index = 'Company Name ', values = 'D/E Ratio')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "c9d95f08-f567-40bd-89c1-834f8672c486",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>D/E Ratio</th>\n",
       "      <th>Total Approved Treatments on the Market in the U.S.A.</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Company Name</th>\n",
       "      <th>Ticker Symbol</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>AbbVie</th>\n",
       "      <th>ABBV</th>\n",
       "      <td>0.526782</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amgen</th>\n",
       "      <th>AMGN</th>\n",
       "      <td>0.432082</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Astrazeneca</th>\n",
       "      <th>AZN</th>\n",
       "      <td>0.312355</td>\n",
       "      <td>41</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bayer</th>\n",
       "      <th>BAYN.DE</th>\n",
       "      <td>1.538355</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bristol-Myers Squibb</th>\n",
       "      <th>BMY</th>\n",
       "      <td>0.439613</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CSL</th>\n",
       "      <th>CSL.AX</th>\n",
       "      <td>0.058800</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Daiichi Sankyo</th>\n",
       "      <th>4568.T</th>\n",
       "      <td>0.130853</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Eli Lilly</th>\n",
       "      <th>LLY</th>\n",
       "      <td>0.131472</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gilead Sciences</th>\n",
       "      <th>GILD</th>\n",
       "      <td>0.560075</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GlaxoSmithKline</th>\n",
       "      <th>GSK</th>\n",
       "      <td>0.797179</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Johnson &amp; Johnson</th>\n",
       "      <th>JNJ</th>\n",
       "      <td>0.225325</td>\n",
       "      <td>67</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Merck</th>\n",
       "      <th>MRK</th>\n",
       "      <td>0.285906</td>\n",
       "      <td>97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Moderna</th>\n",
       "      <th>MRNA</th>\n",
       "      <td>0.108438</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novartis</th>\n",
       "      <th>NVS</th>\n",
       "      <td>0.320000</td>\n",
       "      <td>105</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novo Nordisk</th>\n",
       "      <th>NVO</th>\n",
       "      <td>0.551288</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pfizer</th>\n",
       "      <th>PFE</th>\n",
       "      <td>0.365920</td>\n",
       "      <td>314</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Regeneron Pharmaceuticals</th>\n",
       "      <th>REGN</th>\n",
       "      <td>0.098340</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Roche</th>\n",
       "      <th>ROG.SW</th>\n",
       "      <td>0.233637</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sanofi</th>\n",
       "      <th>SNY</th>\n",
       "      <td>0.406419</td>\n",
       "      <td>73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Vertex Pharmaceuticals</th>\n",
       "      <th>VRTX</th>\n",
       "      <td>0.049534</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         D/E Ratio  \\\n",
       "Company Name              Ticker Symbol              \n",
       "AbbVie                    ABBV            0.526782   \n",
       "Amgen                     AMGN            0.432082   \n",
       "Astrazeneca               AZN             0.312355   \n",
       "Bayer                     BAYN.DE         1.538355   \n",
       "Bristol-Myers Squibb      BMY             0.439613   \n",
       "CSL                       CSL.AX          0.058800   \n",
       "Daiichi Sankyo            4568.T          0.130853   \n",
       "Eli Lilly                 LLY             0.131472   \n",
       "Gilead Sciences           GILD            0.560075   \n",
       "GlaxoSmithKline           GSK             0.797179   \n",
       "Johnson & Johnson         JNJ             0.225325   \n",
       "Merck                     MRK             0.285906   \n",
       "Moderna                   MRNA            0.108438   \n",
       "Novartis                  NVS             0.320000   \n",
       "Novo Nordisk              NVO             0.551288   \n",
       "Pfizer                    PFE             0.365920   \n",
       "Regeneron Pharmaceuticals REGN            0.098340   \n",
       "Roche                     ROG.SW          0.233637   \n",
       "Sanofi                    SNY             0.406419   \n",
       "Vertex Pharmaceuticals    VRTX            0.049534   \n",
       "\n",
       "                                         Total Approved Treatments on the Market in the U.S.A.   \n",
       "Company Name              Ticker Symbol                                                          \n",
       "AbbVie                    ABBV                                                          33       \n",
       "Amgen                     AMGN                                                          25       \n",
       "Astrazeneca               AZN                                                           41       \n",
       "Bayer                     BAYN.DE                                                       25       \n",
       "Bristol-Myers Squibb      BMY                                                           35       \n",
       "CSL                       CSL.AX                                                        20       \n",
       "Daiichi Sankyo            4568.T                                                        12       \n",
       "Eli Lilly                 LLY                                                           46       \n",
       "Gilead Sciences           GILD                                                          27       \n",
       "GlaxoSmithKline           GSK                                                           65       \n",
       "Johnson & Johnson         JNJ                                                           67       \n",
       "Merck                     MRK                                                           97       \n",
       "Moderna                   MRNA                                                           1       \n",
       "Novartis                  NVS                                                          105       \n",
       "Novo Nordisk              NVO                                                           22       \n",
       "Pfizer                    PFE                                                          314       \n",
       "Regeneron Pharmaceuticals REGN                                                           7       \n",
       "Roche                     ROG.SW                                                        47       \n",
       "Sanofi                    SNY                                                           73       \n",
       "Vertex Pharmaceuticals    VRTX                                                           4       "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.pivot_table(df, index = ['Company Name ', 'Ticker Symbol'], values = ['D/E Ratio', 'Total Approved Treatments on the Market in the U.S.A. '])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "b2c07621-a4aa-48a3-bba4-575be9b4068d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>Total in Pipeline</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Company Name</th>\n",
       "      <th>Est. Market Capitalization</th>\n",
       "      <th>No. of Employees</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Roche</th>\n",
       "      <th>247350000000</th>\n",
       "      <th>100920</th>\n",
       "      <td>178</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novartis</th>\n",
       "      <th>187200000000</th>\n",
       "      <th>108000</th>\n",
       "      <td>150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GlaxoSmithKline</th>\n",
       "      <th>83300000000</th>\n",
       "      <th>90096</th>\n",
       "      <td>150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bristol-Myers Squibb</th>\n",
       "      <th>153990000000</th>\n",
       "      <th>32200</th>\n",
       "      <td>114</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Merck</th>\n",
       "      <th>223070000000</th>\n",
       "      <th>67000</th>\n",
       "      <td>109</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Astrazeneca</th>\n",
       "      <th>204620000000</th>\n",
       "      <th>83100</th>\n",
       "      <td>108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pfizer</th>\n",
       "      <th>276440000000</th>\n",
       "      <th>79000</th>\n",
       "      <td>104</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Johnson &amp; Johnson</th>\n",
       "      <th>449870000000</th>\n",
       "      <th>141700</th>\n",
       "      <td>99</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sanofi</th>\n",
       "      <th>124310000000</th>\n",
       "      <th>95442</th>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Eli Lilly</th>\n",
       "      <th>292110000000</th>\n",
       "      <th>35000</th>\n",
       "      <td>84</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AbbVie</th>\n",
       "      <th>243930000000</th>\n",
       "      <th>50000</th>\n",
       "      <td>71</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gilead Sciences</th>\n",
       "      <th>77070000000</th>\n",
       "      <th>14400</th>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Daiichi Sankyo</th>\n",
       "      <th>49270000000</th>\n",
       "      <th>16458</th>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amgen</th>\n",
       "      <th>131630000000</th>\n",
       "      <th>24200</th>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Regeneron Pharmaceuticals</th>\n",
       "      <th>66280000000</th>\n",
       "      <th>10368</th>\n",
       "      <td>41</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bayer</th>\n",
       "      <th>54360000000</th>\n",
       "      <th>95950</th>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CSL</th>\n",
       "      <th>98810000000</th>\n",
       "      <th>25000</th>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Moderna</th>\n",
       "      <th>74310000000</th>\n",
       "      <th>3400</th>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novo Nordisk</th>\n",
       "      <th>262070000000</th>\n",
       "      <th>50816</th>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Vertex Pharmaceuticals</th>\n",
       "      <th>73660000000</th>\n",
       "      <th>3900</th>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                       Total in Pipeline\n",
       "Company Name              Est. Market Capitalization No. of Employees                   \n",
       "Roche                     247350000000               100920                          178\n",
       "Novartis                  187200000000               108000                          150\n",
       "GlaxoSmithKline           83300000000                90096                           150\n",
       "Bristol-Myers Squibb      153990000000               32200                           114\n",
       "Merck                     223070000000               67000                           109\n",
       "Astrazeneca               204620000000               83100                           108\n",
       "Pfizer                    276440000000               79000                           104\n",
       "Johnson & Johnson         449870000000               141700                           99\n",
       "Sanofi                    124310000000               95442                            87\n",
       "Eli Lilly                 292110000000               35000                            84\n",
       "AbbVie                    243930000000               50000                            71\n",
       "Gilead Sciences           77070000000                14400                            60\n",
       "Daiichi Sankyo            49270000000                16458                            45\n",
       "Amgen                     131630000000               24200                            44\n",
       "Regeneron Pharmaceuticals 66280000000                10368                            41\n",
       "Bayer                     54360000000                95950                            39\n",
       "CSL                       98810000000                25000                            32\n",
       "Moderna                   74310000000                3400                             31\n",
       "Novo Nordisk              262070000000               50816                            30\n",
       "Vertex Pharmaceuticals    73660000000                3900                             13"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.pivot_table(df, index = ['Company Name ', 'Est. Market Capitalization', 'No. of Employees'], values = ['Total in Pipeline']).sort_values('Total in Pipeline', ascending = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "4e42928f-3ea9-45fc-869c-8405c5f1d575",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "4a617cda-2a16-4021-ac26-82f15aaacce0",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Rank, Company Age, R&D Expense 3rd Quarter 2021, Est. Market Capitalization, Total Approved Treatments on the Market in the U.S.A., Total Liabilities, Total in Pipeline\n",
    "\n",
    "df_pivots = df[['Rank', 'Company Age', 'R&D Expense 3rd Quarter 2021', 'Est. Market Capitalization', 'Total Approved Treatments on the Market in the U.S.A. ', 'Total Liabilities', 'Total in Pipeline', 'Number of Research Areas Covered by R&D Pipeline']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "8bb936c5-8af8-4f8f-9929-044a5db435a4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rank\n",
      "      Total in Pipeline\n",
      "Rank                   \n",
      "4                   178\n",
      "14                  150\n",
      "9                   150\n",
      "10                  114\n",
      "7                   109\n",
      "8                   108\n",
      "3                   104\n",
      "1                    99\n",
      "12                   87\n",
      "2                    84\n",
      "6                    71\n",
      "15                   60\n",
      "20                   45\n",
      "11                   44\n",
      "18                   41\n",
      "19                   39\n",
      "13                   32\n",
      "16                   31\n",
      "5                    30\n",
      "17                   13\n",
      "Company Age\n",
      "             Total in Pipeline\n",
      "Company Age                   \n",
      "126                        178\n",
      "21                         150\n",
      "26                         150\n",
      "135                        114\n",
      "131                        109\n",
      "23                         108\n",
      "173                        104\n",
      "136                         99\n",
      "49                          87\n",
      "146                         84\n",
      "9                           71\n",
      "35                          60\n",
      "17                          45\n",
      "42                          44\n",
      "34                          41\n",
      "159                         39\n",
      "106                         32\n",
      "11                          31\n",
      "98                          30\n",
      "33                          13\n",
      "R&D Expense 3rd Quarter 2021\n",
      "                              Total in Pipeline\n",
      "R&D Expense 3rd Quarter 2021                   \n",
      "3874.00                                     178\n",
      "2054.00                                     150\n",
      "2380.00                                     150\n",
      "3251.00                                     114\n",
      "2445.00                                     109\n",
      "2152.00                                     108\n",
      "3447.00                                     104\n",
      "3422.00                                      99\n",
      "1701.00                                      87\n",
      "1708.90                                      84\n",
      "4443.00                                      71\n",
      "1147.00                                      60\n",
      "499.00                                       45\n",
      "1422.00                                      44\n",
      "665.00                                       41\n",
      "1844.00                                      39\n",
      "250.25                                       32\n",
      "493.00                                       31\n",
      "1771.00                                      30\n",
      "521.00                                       13\n",
      "Est. Market Capitalization\n",
      "                            Total in Pipeline\n",
      "Est. Market Capitalization                   \n",
      "247350000000                              178\n",
      "187200000000                              150\n",
      "83300000000                               150\n",
      "153990000000                              114\n",
      "223070000000                              109\n",
      "204620000000                              108\n",
      "276440000000                              104\n",
      "449870000000                               99\n",
      "124310000000                               87\n",
      "292110000000                               84\n",
      "243930000000                               71\n",
      "77070000000                                60\n",
      "49270000000                                45\n",
      "131630000000                               44\n",
      "66280000000                                41\n",
      "54360000000                                39\n",
      "98810000000                                32\n",
      "74310000000                                31\n",
      "262070000000                               30\n",
      "73660000000                                13\n",
      "Total Approved Treatments on the Market in the U.S.A. \n",
      "                                                    Total in Pipeline\n",
      "Total Approved Treatments on the Market in the ...                   \n",
      "47                                                              178.0\n",
      "105                                                             150.0\n",
      "65                                                              150.0\n",
      "35                                                              114.0\n",
      "97                                                              109.0\n",
      "41                                                              108.0\n",
      "314                                                             104.0\n",
      "67                                                               99.0\n",
      "73                                                               87.0\n",
      "46                                                               84.0\n",
      "33                                                               71.0\n",
      "27                                                               60.0\n",
      "12                                                               45.0\n",
      "25                                                               41.5\n",
      "7                                                                41.0\n",
      "20                                                               32.0\n",
      "1                                                                31.0\n",
      "22                                                               30.0\n",
      "4                                                                13.0\n",
      "Total Liabilities\n",
      "                   Total in Pipeline\n",
      "Total Liabilities                   \n",
      "57790000000                      178\n",
      "66405000000                      150\n",
      "59904000000                      150\n",
      "67696000000                      114\n",
      "63777000000                      109\n",
      "63914000000                      108\n",
      "101155000000                     104\n",
      "101367000000                      99\n",
      "50522000000                       87\n",
      "38404400000                       84\n",
      "128498000000                      71\n",
      "43165000000                       60\n",
      "6447145180                        45\n",
      "56875000000                       44\n",
      "6518000000                        41\n",
      "83625000000                       39\n",
      "5810000000                        32\n",
      "8058000000                        31\n",
      "144476000000                      30\n",
      "3648700000                        13\n",
      "Total in Pipeline\n"
     ]
    },
    {
     "ename": "ValueError",
     "evalue": "Grouper for 'Total in Pipeline' not 1-dimensional",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-20-d2713d5b2794>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mdf_pivots\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      2\u001b[0m     \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 3\u001b[1;33m     \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mpd\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpivot_table\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdf_pivots\u001b[0m\u001b[1;33m,\u001b[0m\u001b[0mindex\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mi\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mvalues\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;34m'Total in Pipeline'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msort_values\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'Total in Pipeline'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mascending\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;32mFalse\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\reshape\\pivot.py\u001b[0m in \u001b[0;36mpivot_table\u001b[1;34m(data, values, index, columns, aggfunc, fill_value, margins, dropna, margins_name, observed, sort)\u001b[0m\n\u001b[0;32m     93\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mtable\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m__finalize__\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmethod\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;34m\"pivot_table\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     94\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 95\u001b[1;33m     table = __internal_pivot_table(\n\u001b[0m\u001b[0;32m     96\u001b[0m         \u001b[0mdata\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     97\u001b[0m         \u001b[0mvalues\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\reshape\\pivot.py\u001b[0m in \u001b[0;36m__internal_pivot_table\u001b[1;34m(data, values, index, columns, aggfunc, fill_value, margins, dropna, margins_name, observed, sort)\u001b[0m\n\u001b[0;32m    162\u001b[0m         \u001b[0mvalues\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mlist\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mvalues\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    163\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 164\u001b[1;33m     \u001b[0mgrouped\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mdata\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mgroupby\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkeys\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mobserved\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mobserved\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0msort\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0msort\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    165\u001b[0m     \u001b[0magged\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mgrouped\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0magg\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0maggfunc\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    166\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[0mdropna\u001b[0m \u001b[1;32mand\u001b[0m \u001b[0misinstance\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0magged\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mABCDataFrame\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mand\u001b[0m \u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0magged\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\frame.py\u001b[0m in \u001b[0;36mgroupby\u001b[1;34m(self, by, axis, level, as_index, sort, group_keys, squeeze, observed, dropna)\u001b[0m\n\u001b[0;32m   7624\u001b[0m         \u001b[1;31m# error: Argument \"squeeze\" to \"DataFrameGroupBy\" has incompatible type\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   7625\u001b[0m         \u001b[1;31m# \"Union[bool, NoDefault]\"; expected \"bool\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 7626\u001b[1;33m         return DataFrameGroupBy(\n\u001b[0m\u001b[0;32m   7627\u001b[0m             \u001b[0mobj\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   7628\u001b[0m             \u001b[0mkeys\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mby\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\groupby\\groupby.py\u001b[0m in \u001b[0;36m__init__\u001b[1;34m(self, obj, keys, axis, level, grouper, exclusions, selection, as_index, sort, group_keys, squeeze, observed, mutated, dropna)\u001b[0m\n\u001b[0;32m    886\u001b[0m             \u001b[1;32mfrom\u001b[0m \u001b[0mpandas\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcore\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mgroupby\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mgrouper\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mget_grouper\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    887\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 888\u001b[1;33m             grouper, exclusions, obj = get_grouper(\n\u001b[0m\u001b[0;32m    889\u001b[0m                 \u001b[0mobj\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    890\u001b[0m                 \u001b[0mkeys\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\groupby\\grouper.py\u001b[0m in \u001b[0;36mget_grouper\u001b[1;34m(obj, key, axis, level, sort, observed, mutated, validate, dropna)\u001b[0m\n\u001b[0;32m    853\u001b[0m                     \u001b[1;31m# non-unique columns; raise here to get the name in the\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    854\u001b[0m                     \u001b[1;31m# exception message\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 855\u001b[1;33m                     \u001b[1;32mraise\u001b[0m \u001b[0mValueError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34mf\"Grouper for '{name}' not 1-dimensional\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    856\u001b[0m                 \u001b[0mexclusions\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0madd\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    857\u001b[0m             \u001b[1;32melif\u001b[0m \u001b[0mobj\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_is_level_reference\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mgpr\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0maxis\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mValueError\u001b[0m: Grouper for 'Total in Pipeline' not 1-dimensional"
     ]
    }
   ],
   "source": [
    "for i in df_pivots.columns:\n",
    "    print(i)\n",
    "    print(pd.pivot_table(df_pivots,index = i, values='Total in Pipeline').sort_values('Total in Pipeline', ascending = False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "518ef0df-605f-4fa4-a650-ef7985aa8cc6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Number of Research Areas Covered by R&amp;D Pipeline</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>9</th>\n",
       "      <th>11</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R&amp;D Expense 3rd Quarter 2021</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>250.25</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493.00</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499.00</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>521.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1147.00</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1422.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1701.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1708.90</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1771.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1844.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2054.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2152.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2380.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2445.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3251.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3422.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3447.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3874.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4443.00</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Number of Research Areas Covered by R&D Pipeline   3    4    5    6    7   \\\n",
       "R&D Expense 3rd Quarter 2021                                                \n",
       "250.25                                            NaN  NaN  NaN  1.0  NaN   \n",
       "493.00                                            1.0  NaN  NaN  NaN  NaN   \n",
       "499.00                                            1.0  NaN  NaN  NaN  NaN   \n",
       "521.00                                            NaN  NaN  NaN  NaN  NaN   \n",
       "665.00                                            NaN  NaN  NaN  NaN  NaN   \n",
       "1147.00                                           1.0  NaN  NaN  NaN  NaN   \n",
       "1422.00                                           NaN  NaN  NaN  NaN  1.0   \n",
       "1701.00                                           NaN  NaN  NaN  1.0  NaN   \n",
       "1708.90                                           NaN  NaN  1.0  NaN  NaN   \n",
       "1771.00                                           NaN  NaN  NaN  NaN  NaN   \n",
       "1844.00                                           NaN  1.0  NaN  NaN  NaN   \n",
       "2054.00                                           NaN  NaN  1.0  NaN  NaN   \n",
       "2152.00                                           NaN  NaN  NaN  1.0  NaN   \n",
       "2380.00                                           NaN  NaN  NaN  NaN  NaN   \n",
       "2445.00                                           NaN  NaN  NaN  NaN  1.0   \n",
       "3251.00                                           NaN  NaN  NaN  NaN  1.0   \n",
       "3422.00                                           NaN  NaN  NaN  1.0  NaN   \n",
       "3447.00                                           NaN  NaN  NaN  1.0  NaN   \n",
       "3874.00                                           NaN  NaN  NaN  NaN  1.0   \n",
       "4443.00                                           NaN  NaN  NaN  NaN  1.0   \n",
       "\n",
       "Number of Research Areas Covered by R&D Pipeline   9    11  \n",
       "R&D Expense 3rd Quarter 2021                                \n",
       "250.25                                            NaN  NaN  \n",
       "493.00                                            NaN  NaN  \n",
       "499.00                                            NaN  NaN  \n",
       "521.00                                            1.0  NaN  \n",
       "665.00                                            1.0  NaN  \n",
       "1147.00                                           NaN  NaN  \n",
       "1422.00                                           NaN  NaN  \n",
       "1701.00                                           NaN  NaN  \n",
       "1708.90                                           NaN  NaN  \n",
       "1771.00                                           NaN  1.0  \n",
       "1844.00                                           NaN  NaN  \n",
       "2054.00                                           NaN  NaN  \n",
       "2152.00                                           NaN  NaN  \n",
       "2380.00                                           1.0  NaN  \n",
       "2445.00                                           NaN  NaN  \n",
       "3251.00                                           NaN  NaN  \n",
       "3422.00                                           NaN  NaN  \n",
       "3447.00                                           NaN  NaN  \n",
       "3874.00                                           NaN  NaN  \n",
       "4443.00                                           NaN  NaN  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.pivot_table(df_pivots, index = 'R&D Expense 3rd Quarter 2021', columns = 'Number of Research Areas Covered by R&D Pipeline', values = 'Total Approved Treatments on the Market in the U.S.A. ', aggfunc = 'count')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "fc5f6b33-9961-4f67-9e9c-04ba09f708a4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'Company Name ', 'Ticker Symbol', 'Country of Origin',\n",
       "       'Company Age', 'Est. Market Capitalization', 'Total Liabilities',\n",
       "       'D/E Ratio', 'R&D Expense 3rd Quarter 2021',\n",
       "       'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
       "       'R&D Expense 3rd Quarter 2018',\n",
       "       'Number of Research Areas Covered by R&D Pipeline',\n",
       "       'No. of Ongoing Phase 1 Clinical Trials',\n",
       "       'No. of Ongoing Phase 2 Clinical Trials',\n",
       "       'No. of Ongoing Phase 3 Clinical Trials', 'Filed', 'Total in Pipeline',\n",
       "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
       "       'No. of Employees'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "0a2ae8a6-f101-4863-bde9-c419092a15f9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:>"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "cmap = sns.diverging_palette(220, 10, as_cmap=True)\n",
    "sns.heatmap(df[['Company Age', 'Est. Market Capitalization',\n",
    "       'D/E Ratio', 'R&D Expense 3rd Quarter 2020', 'R&D Expense 3rd Quarter 2019',\n",
    "       'R&D Expense 3rd Quarter 2018',\n",
    "       'Total Approved Treatments on the Market in the U.S.A. ',\n",
    "       'No. of Employees']].corr(), vmax=.3, center=0, cmap=cmap, square=True, linewidth=.5, cbar_kws={\"shrink\": .5})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f3e36790-f24a-4c14-bd9f-0b55226f3d3b",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
